This site is intended for health professionals only

Trial backs Cycloset safety profile

teaser

Article continues below this sponsored advert
Advertisement

A significant reduction in the risk of diabetic cardiovascular complications has been noted in subjects with type 2 diabetes treated with Cycloset






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x